马来西亚淋巴瘤FDG PET-CT报告格式共识声明
该共识由马来西亚核医学医师与血液科医师组成的委员会制定,针对淋巴瘤18F-FDG PET-CT报告格式提出联合推荐。共识旨在减少观察者间报告差异,便于转诊临床医生理解报告,并促进医患沟通。原文提及Deauville评分系统(2009)和淋巴瘤疗效评估标准(2014)作为共同语言基础。
要点
- 推荐采用标准化报告格式以减少观察者间差异。
- 报告应便于转诊临床医生理解和患者沟通。
- 结合Deauville评分和淋巴瘤疗效评估标准进行报告。
诊断标准与关键数值
- 报告格式推荐基于Deauville评分系统(2009)和淋巴瘤疗效评估标准(2014)。
临床应用与阅片要点
- 采用标准报告格式可减少观察者间报告差异。
- 报告格式应便于转诊临床医生理解及医患沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the past decade, 18F-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PETCT) has emerged as an important imaging modality in the management of lymphoma. Since the introduction of Deauville scoring system (2009) and the Lymphoma Response Assessment Criteria (2014), clinicians are now sharing a common language in the management of lymphoma. In Malaysia, nearly a third of PET-CT request is related to lymphoma imaging. Though there are extensive publications regarding these scoring systems and assessment criteria for lymphoma, there are hardly any literature on the reporting format for the 18F-FDG PET-CT in this disease. The variable reporting formats have on many occasions caused confusion not only to the referring clinicians but also to nuclear medicine physicians. Thus, a working committee comprising experienced nuclear medicine physicians and haematologists in Malaysia have agreed and made a joint recommendation on the standard reporting format for 18F-FDG PET-CT in Lymphoma. This recommendation will minimize inter-observer discrepancies in reporting, facilitate the understanding of the report of the referring clinicians as well as facilitate counseling between patients and clinicians in the management of the disease.
引用
- Tan TH, Wong TH, Khoo CH, et al. Malaysian consensus statement on FDG PET-CT reporting format for lymphoma. Med J Malaysia. 2021. PMID: 34508375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。